Creatio, the Production and Validation Center for Advanced Therapies of the University of Barcelona, has taken part in the production of viruses that act as vectors for the CAR-T ARI-0001 drug, approved by the Spanish Agency of Medicines and Medical Devices (AEMPS) and carried out by the Hospital Clínic de Barcelona.

https://www.ub.edu/creatio/#!/home